Vertex Pharmaceuticals
VRTX
#168
Rank
$82.33 B
Marketcap
$320.76
Share price
1.38%
Change (1 day)
71.58%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2022 (TTM): $4.08 B

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.08 B. In 2021 the company made an earning of $2.79 B a decrease over its 2020 earnings that were of $3.17 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 2003 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$4.08 B46.31%
2021$2.79 B-12.06%
2020$3.17 B118.45%
2019$1.45 B129.12%
2018$0.63 B1415.4%
2017$41.86 M197.6%
2016$14.06 M-102.97%
2015-$0.48 B-28.53%
2014-$0.67 B-51.52%
2013-$1.37 B-32098.55%
2012$4.27 M
2010-$0.74 B24.05%
2009-$0.6 B
2007-$0.42 B83.1%
2006-$0.23 B59.02%
2005-$0.15 B3.28%
2004-$0.14 B-37.83%
2003-$0.23 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$22.51 B 451.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.78 B 261.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.54 B 11.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.77 B 335.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.71 B 88.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.14 B-103.20%๐Ÿ‡บ๐Ÿ‡ธ USA